ULTRAGENYX EUROPE GMBH
502078-5456ActiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Biopharmaceutical Companyultragenyx.com
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2022
- Grunnlagt
Nøkkelbeslutningstakere
Emil D. Kakkis
Chief Executive Officer and President
Beskrivelse
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Tagger
B2BB2C
Nøkkelord
Biopharma